As the most commonly altered driver genes, mutations in TP53 and TERT were both identified in 7 of 11 (64%) HCC patients, and different tumor lesions shared TP53 or TERT promoter alterations except for three patients (HCC05, HCC07 and HCC08’s T3). Here, TERT is linked to neoplasm.